Sign In
Buy DIOD
$116.22
+2.09 (+1.83%)
At Close: Jun 03, 2026
Vir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in August
09:05pm, Tuesday, 11'th Aug 2020
Vir Biotechnology Inc said on Tuesday it plans to start a mid-to-late stage trial of its COVID-19 drug candidate in August, as drugmakers across the globe rush to find treatments for the highly infect
India's shortage of remdesivir is easing, says producer Cipla
02:28pm, Tuesday, 11'th Aug 2020
India's supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, according to a top executive at one of the country's big
China National Medical Products Administration Approves Truvada® for HIV Pre-Exposure Prophylaxis (PrEP)
12:11pm, Tuesday, 11'th Aug 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the China National Medical Products Administration (NMPA) has approved a pre-exposure prophylaxis indication for Truvada (emtricitabine 200 mg
Gilead Submits New Drug Application With FDA For Remdesivir
06:33pm, Monday, 10'th Aug 2020
Gilead Sciences Inc. announced on Monday that it has filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for remdesivir, its investigational antiviral for the treatment o
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19
03:00pm, Monday, 10'th Aug 2020
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Veklury® (remdesivir), an investigational an
Pfizer Inks Deal To Manufacture Gilead’s Covid-19 Remdesivir Treatment
11:06am, Monday, 10'th Aug 2020
Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir.Financial details weren’t disclosed. Under the terms
A Big Pension Bought GE, Merck, and Intel Stock. It Sold This Biotech.
11:00am, Sunday, 09'th Aug 2020
The State of Michigan Retirement System bought more General Electric, Merck, and Intel stock in the second quarter, and sold most of its investment in biotech stock Gilead Sciences.
These Chip Stocks Jumped On Upbeat Earnings Reports
08:23pm, Friday, 07'th Aug 2020
Amid a mixed week for chip company earnings, two semiconductor stocks got a boost from beat-and-raise reports. SiTime and Synaptics cheered investors with their results and guidance.
Pfizer Will Help Gilead Sciences Make Its Covid-19 Treatment, Remdesivir
03:04pm, Friday, 07'th Aug 2020
The drug giant is one of the firms that will manufacture remdesivir, Gilead Sciences’ experimental antiviral that got emergency approval in May as a treatment for Covid-19.
NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment
01:11pm, Friday, 07'th Aug 2020
The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.'s remdesivir with Merck KGaA's interferon beta-1a as a tr
Pfizer to help manufacture Gilead's remdesivir
12:10pm, Friday, 07'th Aug 2020
Shares of Pfizer Inc. gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s COVID-19 treatment remdesivir as part of a multi-year agreeme
Pfizer signs deal to supply Gilead's remdesivir for COVID-19
12:07pm, Friday, 07'th Aug 2020UK's Hikma starts manufacturing COVID-19 treatment remdesivir for Gilead
08:00am, Friday, 07'th Aug 2020
Hikma Pharmaceuticals has started manufacturing remdesivir, an approved treatment for COVID-19 from U.S.-based Gilead, for an undisclosed amount at its facility in Portugal, the British company's chie
Diodes (DIOD) Q2 Earnings and Revenues Top Estimates
09:35pm, Thursday, 06'th Aug 2020
Diodes (DIOD) delivered earnings and revenue surprises of 8.00% and 2.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
